Pharma Reviews: Gland Pharma IPO opens today I Here is in depth analysis of the issue

The company follows a diversified B2B-led model across markets globally, complemented by a targeted B2C model in India. The US accounts for 67% of ...
Read more: Gland Pharma IPO opens today I Here is in depth analysis of the issue